Pharma IQ

Welcome to the AI for Pharma and Healthcare Summit 🌟 This unmissable forum is centred on real-world AI use cases across drug discovery, clinical trials and supply chain/manufacturing https://lnkd.in/eFGsEtuk Shift your AI strategy from Hype to Reality as we hear how leaders such as Syneos Health, Novartis, Sanofi, GSK, IHH Healthcare, Pfizer and over 25 more are driving AI implementation to elevate #patientcare across the entire value stream. Learn more here: https://lnkd.in/eFGsEtuk

🚀 AI in Healthcare: Are We Really Unlocking Its Full Potential? We’ve all seen the numbers—nearly 1,000 AI-enabled medical devices authorized by the FDA as of 2024, as highlighted in this recent MedTech Dive article. Impressive, right? But here’s the real question: ARE WE MOVING FAST ENOUGH TO HARNESS AI’S TRUE IMPACT ON HEALTHCARE? It feels like we’re stuck in a loop of celebrating approvals, but what about REAL-WORLD INTEGRATION? We’re running the risk of AI FATIGUE, where devices look promising on paper but don’t yet deliver the game-changing outcomes we’re all hoping for. 💡 WHAT IF THE REAL OPPORTUNITY ISN’T JUST AI IN DEVICES BUT BUILDING AI ECOSYSTEMS? Imagine interoperable AI tools that talk to each other across clinical trials, EHR systems, patient monitoring, and diagnostics. It’s time to shift the focus from device-by-device progress to SYSTEM-LEVEL INNOVATION. And while we’re at it—WHO’S TRULY BENEFITING from all these breakthroughs? Are these innovations reaching underrepresented populations, or staying confined to high-end institutions? AI in healthcare is only as revolutionary as the people it serves. Lastly, the REAL SILENT REVOLUTION might not be happening in the diagnostic suite, but in BACK-OFFICE OPERATIONS. AI that streamlines clinical trial workflows, automates patient recruitment, and eliminates bottlenecks could end up having a bigger impact on patient outcomes than the devices we focus on. #DigitalHealth #AI #HealthcareInnovation #ClinicalTrials #MedTech https://lnkd.in/esWGiJDu t

The pharmaceutical industry is undergoing a transformative period, with geopolitical challenges, regulatory shifts, and supply chain disruptions all resulting in a need for more resilient and adaptable manufacturing strategies. CMOs & CDMOs now play an increasingly pivotal role in addressing these challenges, but how do you create a long-lasting relationship? Find out more...

🔍 Patient engagement is evolving from patient-centricity to true patient leadership in the digital age 🔍 Pharmaceutical companies are increasingly recognising the power of social media to connect with patient communities. But moving beyond just “patient-centric” campaigns to genuine patient-led experiences is crucial for creating meaningful impact. From co-creating campaigns with patient groups to addressing unmet needs through AI-driven insights, the future of pharma communications is about empowering patients and truly listening to their voices. 📊 In our latest interview with Jenny Ousbey CEO of OVID Health, we discuss insights from their new global report, From Patient Centricity to Patient Leadership, and explore how companies can better engage with patients in the digital age. We talk about key trends, successful strategies, and what’s next for pharma-patient engagement on social media. 📝 Read the full interview here: https://lnkd.in/eKdWJ4eU The article also includes details of how to access the full OVID Health report. Jenny Ousbey William Brennan #PharmaEngagement #PatientLeadership #DigitalHealth #PatientAdvocacy #HealthcareCommunications #PharmaIQ #SocialMediaInHealthcare #OVIDHealth

🚀 The Future of Healthcare is Being Shaped by Technology – But Only if We Can Overcome System Silos 🚀 As healthcare organisations face increasing pressures—workforce shortages, rising costs, and ever-changing regulatory demands—technology is stepping up to offer transformative solutions. But with legacy systems and fragmented data holding many organisations back, how can healthcare truly embrace digital transformation? Enter Enterprise Architecture (EA) – a comprehensive framework that helps healthcare leaders integrate their IT ecosystems, streamline operations, and improve patient care. EA not only breaks down system silos but also provides real-time operational insights, allowing organisations to plan strategically and optimise their technology investments. In this guest article, Rupert Colbourne, Chief Technology Officer at Orbus Software, explores how EA is reshaping the healthcare industry. From addressing technical debt to enhancing patient experiences, Rupert breaks down how EA offers healthcare organizations a way to thrive in today’s digital-first world. 📝 Read the full article here: https://lnkd.in/eq4AqE7Q Rupert Colbourne Orbus Software Flora Davies #HealthcareInnovation #EnterpriseArchitecture #DigitalTransformation #PatientExperience #HealthcareTechnology #PharmaIQ #OrbusSoftware

🚀 Reflecting on the insightful discussions at the AI for Pharma & Healthcare Summit 🚀 Our conversations at the event highlighted how AI is driving transformation across the healthcare ecosystem, from improving drug discovery to enhancing patient care. One major theme that stood out was the importance of balancing AI-driven efficiency with the irreplaceable value of human interaction – a topic we continue to explore in our latest Pharma IQ interview. 📝 Check out our new interview with Sophie Kynnersley from Cymphony as we dive deeper into the future of healthcare communications. From the role of AI in improving operational efficiencies to the importance of personalised patient care, this article explores how technology is shaping the patient experience and clinic operations. 🔗 Read the full interview here: https://lnkd.in/er36c5xn Sophie Kynnersley Nathan Patel Cymphony #AIinHealthcare #HealthcareCommunications #PatientExperience #DigitalTransformation #OperationalEfficiency #AI #HumanCenteredCare #PharmaIQ

Excited to share that I had the chance of attending and speaking at the AI for Pharma & Healthcare conference! 🎉 It was an incredible opportunity to discuss the latest advancements in AI and their transformative impact on the pharmaceutical and healthcare industries. It was great presenting alongside Jonathan Crowther on the topic of genAI in clinical trial feasibility, exploring how AI can revolutionize the way we approach and conduct clinical trials. It was fantastic to connect with so many professionals and exchange ideas on how we can drive innovation in our field. Looking forward to implementing these insights and continuing to push boundaries. #AIinPharma #AI #Pharma #Healthcare #Innovation #ClinicalTrials

💡 My thoughts on what’s stopping the uptake of AI in healthcare 🤔 At our latest workshop at the AI for Pharma & Healthcare conference https://lnkd.in/d9iSf5_N in Amsterdam, Paula Salme Sandrak and I asked our audience about the challenges they’re facing when developing health AI solutions. The image you see here describes the responses. What stood out for me was the following comment: "Shiny new toy." I get it but I also don’t get it all… Even though I’ve worked in healthcare now for well over a decade, as an AI engineer, I’m always somewhat of an outsider. There are also perks to this, as it gives me some outside perspective. What I’m noticing when listening to healthcare business leaders, is that they seem to mix up simple automation and robotics with the real potential of AI in healthcare. By definition, shiny new toys are designed for temporary, gratifying, yet short-term use. This is NOT what role AI is going to play in healthcare. Let me be clear. AI is not just speed and automation. I’m surprised that many decision makers still don't fully recognize this, even though we all have access to way more advanced, high-performing AI tools that demonstrate a potential that goes way beyond the commonly used LLMs. So what is the extent of this potential? AI will not only help you reach your goals faster, it can also guide you to discover completely new goals. AI can help to understand ecosystems, incl. healthcare ecosystems, more effectively, using angles that humans alone may not even consider. It’s easy to be trenched in old workflows, old disease models, and see anything new as a threat. AI can not just suggest these new ways but it can also help effectively define futures that seem so out of the typical way of thinking, yet abide by the values and needs defined by us.  While much is said about the risks of AI, and extensive efforts made to implement regulations, I would encourage us to be more balanced. It’s important to recognize that AI itself does not inherently make decisions that are risky or beneficial—it is us, humans, who control and direct these tools. To give an example: imagine the effort required to discover how a traumatic childhood event might affect someone's lifestyle, leading to hypertension in their 40s. 🧠➡️❤️ If we had the necessary longitudinal data for such a study, AI could potentially uncover this correlation. Now, forget why we might need this specific study—the real question is: how much would our understanding of certain diseases change if we allow AI to reveal such insights? 🧩🔬 So, we’re not just looking at a tool that saves time/costs—AI is pushing us toward a deeper understanding of the world. 🌍 Don’t get me wrong, we’re not becoming all-knowing gods, but : AI is here to stay. No matter what the next shiny new toy is, AI is not one of them. #DigitalTwins #HealthcareTransformation #AIForGood

🚨 AI in Pharma: Will the Big Get Bigger? 🚨 AI is transforming the pharma industry. But here's the catch—while AI's potential is massive, it might not benefit everyone equally. 💡 Who stands to gain the most? The big players with deep pockets and access to vast data are poised to dominate. They can leverage AI for faster drug discovery and optimized R&D efficiency. 📈 On the other hand... AI skeptics, take note: AI doesn't replace human expertise—it enhances it. For those at the cutting edge, it's time to double down on strategic partnerships and innovations that maximize AI's impact. 💼🤖 Ready for more insights? 🔗 [Read the full article](https://buff.ly/47Wej0i) --- 📣 What are your thoughts? Will AI level the playing field or make the big even bigger? Let’s discuss below! 👇 P.S. Reshare this if you found it insightful! ♻️

Wow, It's already been a week since I presented at the AI for Pharma & Healthcare launch conference in Amsterdam. I was lucky to also host the Drug Design stream over the conferences two days. There were lots of fantastic insights on how AI can elevate drug discovery and drug design, and I enjoyed chatting to everyone. My presentation was on how quantum computing can contribute to every step of the vlaue chain, not just drug discovery. I'm already looking forward to next years event. Big thanks to Nikki Kandola for organising and inviting me along and to Neil Ewington to chairing the event so well. #AI  #AIinPharma #PharmaIQ